KARISSA BIRD: Open Payments
NPI 1659073625 · EDGEWOOD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,238 in 14 payments from 7 companies in 2025. Trend: 2023 $20 · 2024 $148 · 2025 $1,238
Food & beverage: $1,238
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $418 |
| Penumbra, Inc. | 3 | $389 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $146 |
| PFIZER INC. | 2 | $135 |
| Actelion Pharmaceuticals US, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Novo Nordisk Inc | 1 | $14 |
Products named: REPATHA, Indigo System, Penumbra System, Kerendia, VYNDAQEL, UPTRAVI, FARXIGA, Wegovy.
Industry payments across KY — which companies pay providers there.
